Does CYCLOPHOSPHAMIDE Cause Drug ineffective for unapproved indication? 1,097 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,097 reports of Drug ineffective for unapproved indication have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.9% of all adverse event reports for CYCLOPHOSPHAMIDE.
1,097
Reports of Drug ineffective for unapproved indication with CYCLOPHOSPHAMIDE
0.9%
of all CYCLOPHOSPHAMIDE reports
334
Deaths
303
Hospitalizations
How Dangerous Is Drug ineffective for unapproved indication From CYCLOPHOSPHAMIDE?
Of the 1,097 reports, 334 (30.4%) resulted in death, 303 (27.6%) required hospitalization, and 106 (9.7%) were considered life-threatening.
Is Drug ineffective for unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 1,097 reports have been filed with the FAERS database.
What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?
Off label use (12,578)
Febrile neutropenia (11,318)
Drug ineffective (8,142)
Neutropenia (7,352)
Disease progression (7,100)
Pyrexia (6,126)
Product use in unapproved indication (5,750)
Thrombocytopenia (4,669)
Pneumonia (4,595)
Nausea (4,561)
What Other Drugs Cause Drug ineffective for unapproved indication?
GABAPENTIN (5,231)
METHOTREXATE (2,513)
DICLOFENAC (2,154)
RITUXIMAB (1,776)
LIDOCAINE (1,761)
METHYLPREDNISOLONE (1,750)
PREDNISONE (1,598)
MYCOPHENOLATE MOFETIL (1,596)
HUMAN IMMUNOGLOBULIN G (1,527)
DEXAMETHASONE (1,302)
Which CYCLOPHOSPHAMIDE Alternatives Have Lower Drug ineffective for unapproved indication Risk?
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE
CYCLOPHOSPHAMIDE vs CYCLOSERINE
CYCLOPHOSPHAMIDE vs CYCLOSPORINE